Bausch Health Companies (BHC) Current Assets (2009 - 2026)
Bausch Health Companies (BHC) posted Current Assets of $6.5 billion for Q2 2026, up 9.1% sequentially from $6.0 billion in Q1 2026, and little changed YoY from $6.5 billion in Q2 2025.
Bausch Health Companies (BHC) Current Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Current Assets for 18 years, with the latest figure at $6.5 billion in Q2 2026.
- Quarterly Current Assets changed 0.12% year-over-year to $6.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.5 billion (changed 0.12% YoY) and the FY2025 annual result came in at $6.2 billion, up 6.63% from the prior year.
- Current Assets climbed to $6.5 billion in Q2 2026 per BHC's latest filing, from $6.0 billion in the prior quarter.
- Over five years, Current Assets peaked at $6.5 billion in Q2 2026 and troughed at $4.0 billion in Q3 2022.
- A 5-year average of $5.4 billion and a median of $5.5 billion in 2022 frame the typical range for Current Assets.
- The widest YoY moves for Current Assets: up 31.76% in 2023, down 27.4% in 2023.
- Over 5 years, Current Assets stood at $4.2 billion in 2022, then soared by 31.76% to $5.6 billion in 2023, then increased by 3.18% to $5.8 billion in 2024, then advanced by 6.63% to $6.2 billion in 2025, then increased by 5.93% to $6.5 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $6.5 billion, $6.0 billion, and $6.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.22 Bn |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | 6.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.52 Bn |
| Mar 31, 2026 | 5.98 Bn |
| Dec 31, 2025 | 6.16 Bn |
| Sep 30, 2025 | 6.25 Bn |
| Jun 30, 2025 | 6.51 Bn |
| Mar 31, 2025 | 5.73 Bn |
| Dec 31, 2024 | 5.77 Bn |
| Sep 30, 2024 | 5.35 Bn |
| Jun 30, 2024 | 5.21 Bn |
| Mar 31, 2024 | 5.40 Bn |
| Dec 31, 2023 | 5.60 Bn |
| Sep 30, 2023 | 5.05 Bn |
| Jun 30, 2023 | 4.46 Bn |
| Mar 31, 2023 | 4.24 Bn |
| Dec 31, 2022 | 4.25 Bn |
| Sep 30, 2022 | 4.01 Bn |
| Jun 30, 2022 | 5.42 Bn |
| Mar 31, 2022 | 5.84 Bn |
| Dec 31, 2021 | 5.61 Bn |
| Sep 30, 2021 | 5.32 Bn |